AKR1C1 and colorectal adenocarcinoma: Conversely, nontoxic doses of SFN (50 μM) caused an increase in the catalytic activity, protein and mRNA levels of AKR1C1 in human colorectal adenocarcinoma Caco-2 cells [25].